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Abstract 
 
The mesangium plays a prominent role in maintaining glomerular homeostasis by 
contributing to hemodynamic regulation, macromolecule clearance, and immune 
monitoring. However, it is also intimately involved in the development of glomerular 
disease. In this work we examine the physics of transport in the mesangial region by 
creating a computational model. This model suggests that physiological parameters play a 
key role in controlling the distribution of macromolecules within the mesangium. In 
particular, it suggests that aberrant glycosylation of IgA in IgA nephropathy may be 
damaging because of how it changes the Péclet number.  
The model is then extended to describe transport within the glomerular tuft 
through the mesangial matrix. Again, we examine this transport under a range of 
physiological parameters. Our results suggest that transport within the mesangium may 
operate as one of two broad regimes – an “accumulating” regime where the mesangium 
provides additional filtration surface area and large macromolecules may accumulate in 
the region, and a “shunting” regime where the mesangium allows solutes to bypass the 
full length of glomerular capillary filtration 
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Chapter 1: Introduction 
 
 The kidneys are critically important to several body functions including eliminating 
waste, maintaining salt balance, and regulating blood pressure. They filter the blood 
supply, processing about 180 L/day in humans (18). Each human kidney is composed of 
about one million nephrons, the unit of blood filtration and waste processing. Each 
nephron is composed of a glomerulus, the site of initial blood filtration, and associated 
tubule. A sketch of a nephron is shown in figure 1-1, with the kidney glomerulus in the 
upper left. The glomerulus is a spherical network of fenestrated glomerular capillaries. 
High hydrostatic pressure within the glomerular capillaries drives filtration across the 
capillary walls. The glomerular filter consists of the fenestrated endothelium, the 
basement membrane on which the endothelial cells sit, and interdigitated podocytes, 
which are specialized epithelial cells on the capillary exterior. Blood plasma and small 
solutes pass through this filtration process and enter the urinary space surrounding the 
glomerulus. This initial filtrate then enters the tubule, where it is further processed, before 
exiting the nephron as urine. 
 This work focuses on the glomerulus, and in particular on the role of a glomerular 
substructure, the mesangium. Outlined in hatched gray in figure 1-2, the mesangium is 
centrally located in the glomerulus, and intimately connected with the fenestrated 
endothelium (77, 79). Composed of resident smooth-muscle-like mesangial cells and 
their associated matrix (mesangial matrix), the mesangium is directly involved in both 
maintaining glomerular health and in the pathogenesis of glomerular diseases. The 
mesangium provides structural support for the glomerular capillaries, communicates with 
  2 
endothelial cells and podocytes, assists in regulating glomerular hemodynamics, and 
clears dead cells and macromolecules that accumulate in the region. Additionally it is 
involved in the pathogenesis of multiple glomerular diseases, including IgA nephropathy, 
membranoproliferative glomerulonephritis, and diabetic nephropathy (20). 
 Mesangial cells provide the necessary structural support that closes the glomerular 
capillary loop. Mesangial cells insert into the basement membrane (GBM), and develop 
contractile microfilament bundles that hold opposite sides of the GBM against 
intracapillary pressure (49, 77). Experimental models that directly injure or lyse 
mesangial cells have shown that when mesangial cells fail, glomerular capillaries may 
balloon, microaneurysms can develop, and, in the most extreme case, glomerular 
architecture may be lost completely (49, 60, 94). Even models that only disrupt mesangial 
cells’ mechanical attachments to the GBM, but leave them otherwise functional, will alter 
glomerular hemodynamics by increasing glomerular filtration, most likely through 
expansion and additional filtration in the mesangial region (49). 
 Mesangial cells are also involved in continual cross-talk with the other glomerular 
cell types. Mesangial cells rely on endothelial production of PDGF-B to grow and persist, 
and loss of endothelial cells results in mesangial cell death (79). Additionally, mesangial 
cells and podocytes produce chemokines that can bind to each other’s receptors (79). 
Beyond mesangial-podocyte and mesangial-endothelial communication, mesangial cells 
also possess gap junctions (96), and are contiguous with the extraglomerular mesangium 
(59, 95). Extraglomerular mesangial cells have a demonstrated role in tubuloglomerular 
feedback (TGF) (75). The intraglomerular mesangium’s electrical connection to this 
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structure raises the possibility of extraglomerular to intraglomerular mesangial 
communication and involvement in TGF. 
 There is support for a mesangial role in hemodynamic regulation. After 
experimental mesangial cell lysis, the glomerular ultrafiltration coefficient is reduced and 
GFR falls (93). Normal glomerular filtration rate (GFR) and capillary pressure responses 
to plasma volume expansion (PVE) are also lost; glomeruli without mesangial cells do 
not increase SNGFR in response to PVE (6). Glomerular response to angiontensin II 
(Ang II) administration is attenuated in the absence of mesangial cells – Ang II 
administration does not decrease SNGFR (6). In culture, mesangial cells contract in 
response to Ang II (89), but the connection to the observed hemodynamic behaviors in 
vivo has not been established. 
 Multiple tracer studies have demonstrated that large molecules or nanoparticles 
preferentially accumulate within the mesangial region (14, 28, 29, 48, 57, 84). Mesangial 
cells may phagocytose these molecules to some extent (58), but an additional clearance 
route runs from within the glomerular mesangium to the extraglomerular mesangium, 
followed by secretion into the proximal tubule (53). The mesangium also has a resident 
population of myeloid dendritic cells (59) with strong phagocytic propensities, and 
mesangial cells themselves possess immunoglobulin receptors (26, 59, 80). The 
mesangial environment thus presents an ideal location for monitoring overall blood 
composition. Key analytes accumulate in the region, and it is intimately connected with 
the structures controlling glomerular filtration (JGA and macula densa). 
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 The mesangium thus assists in maintaining homeostasis in healthy glomeruli. 
However, disease can disturb these maintenance processes, resulting in progression of the 
disease rather than resolution. The mesangium responds early to glomerular diseases (9, 
36), and one initial indicator is often mesangial proliferation and matrix deposition (1). 
Exogenous TGF-β can stimulate extracellular matrix deposition in mesangial cells (8). 
Activation of mesangial cells by immune complexes results in the release of several 
interleukins, tumor necrosis factor (TNF), reactive oxygen species, and extracellular 
matrix deposition (20, 59, 70). Clearly, mesangial cells can have strong pro-inflammatory 
effects. Additionally, there is a small subpopulation of immunologically active cells that 
seem to permanently reside in the mesangium (20). When activated, these cells, in 
combination with activated mesangial cells, can then attract invading macrophages (70). 
All of this inflammatory activity and mesangial matrix expansion leads to stiffening of 
the glomerulus, and potentially to podocyte death, which in turn may lead to complete 
loss of glomerular function (59).  
 All of this research reveals the mesangium’s critical role in maintaining glomerular 
health, and its contribution to the progression of glomerular disease. However, our 
understanding of filtration and solute transport in the mesangial microenvironment 
remains incomplete. In contrast, filtration through the glomerular capillary wall has been 
well studied both in vivo and computationally. The ability to measure glomerular 
filtration rate either for the whole subject (85) or in a single nephron (17)  has allowed 
characterization of the filtration process under many different conditions. The work of 
Deen and colleagues (21, 27, 64)  has afforded major theoretical insights into aspects of 
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transport across the glomerular capillary wall. Since a vast majority of the plasma 
filtration occurs through the capillary wall rather than through the mesangium, these 
studies have provided little information about mesangial transport, but they have helped 
to create an accurate vision of the glomerular capillary milieu. 
 The major focus of this work is on modeling the physical mechanisms behind the 
mesangium’s maintenance of homeostasis and contribution to disease progression. The 
aim is to 1) describe the underlying physics of mesangial transport, and 2) examine the 
influence of physiological parameters on that transport.  A model of transport in the 
mesangium may explain the observed macromolecule accumulation in the region. The 
model is also extended to include the larger context of the glomerular tuft. The 
mesangium’s central location suggests that plasma flowing through the mesangial matrix 
could bypass glomerular filtration, and solutes might move through the region from the 
afferent to the efferent capillary.  We develop a model to account for this flow and 
examine what physiological conditions influence the mesangium’s ability to concentrate 
key solutes (amplifying a signal for sensing) or to bypass filtration. 
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Figure 1-1: A diagram of a kidney's nephron. Initial blood filtration takes place in the glomerular 
capsule. The filtrate formed then enters the proximal tubule, and is processed through the loop of the 
nephron. Urine flows out the collecting duct. Used with permission from (99). Download for free at 
http://cnx.org/contents/14fb4ad7-39a1-4eee-ab6e-3ef2482e3e22@8.81 
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Figure 1-2: Cross-sectional sketch of a glomerular capillary. The mesangium occupies the central 
portion, drawn in the hatched gray. The blue cells are the specialized epithelial cells, podocytes. The 
basement membrane is outlines in thick black, and the endothelial cells are shown as the fenestrated 
lining of the capillary lumens. Republished with permission of  JASN, from (44); permission 
conveyed through Copyright Clearance Center, Inc 
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Chapter 2: Modeling mesangial accumulation in IgA 
nephropathy 
This chapter is part of the manuscript:  
Hunt, S. E., Dorfman, K. D., Segal, Y., & Barocas, V. H. (2016). A computational model 
of flow and species transport in the mesangium. American Journal of Physiology-Renal 
Physiology, 310(3), F222-F229. 
 
2.1 Summary 
 As discussed in the introduction, a variety of macromolecules accumulate in the 
glomerular mesangium in many different diseases.  In this chapter we studied the physics 
of the transport of these molecules within the porous mesangial matrix, using a 
computational model of convection and diffusion, and we applied this model to the 
specific instance of immunoglobulin A (IgA) transport in IgA nephropathy. We examined 
the influence of physiological factors including glomerular basement membrane (GBM) 
thickness and mesangial matrix density on the total accumulation of IgA. Our results 
suggested that IgA accumulation can be understood by relating convection and diffusion, 
and that the relative strength of these effects depend strongly on intrinsic glomerular 
factors. 
 
2.2 Introduction 
 The objectives of this chapter were 1) to develop a computational model of plasma 
and species transport within the mesangium, and 2) to apply that model to the question of 
how different factors contribute to the mesangial accumulation of IgA in IgA 
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nephropathy. IgA nephropathy may be considered archetypal; the disease, which has 
been associated with a number of different contributory/causative factors (2, 5, 37, 45, 
61, 62, 92), hinges upon aberrant biodistribution, with the defining symptom being 
accumulation of IgA in the mesangium. The key result of our analysis is the recognition 
that IgA nephropathy may be considered in terms of the transport of IgA, whereupon 
many disparate physiological states can be attributed to changes in the Péclet number 
governing the relative effects of convective transport in flow to diffusion of IgA. 
 
Glossary 
a         Radius of diffusing molecule 
a1, a2  Osmotic pressure coefficients 
calb      Albumin concentration 
D0       Free diffusion coefficient, calculated from the Stokes-Einstein equation 
Dalb     Diffusion coefficient of albumin 
δPFB    Thickness of the filtration barrier (basement membrane + podocytes) 
kB       Boltzmann constant 
KD,mes Hydraulic conductivity of the mesangial matrix 𝐾𝐷 = 𝜅/𝜇 
KD,PFB Hydraulic conductivity of the perimesangial filtration barrier 
κ        Tissue Darcy permeability 
μ        Plasma viscosity 
λ        Ratio of molecule radius to fiber radius 
p        Hydrostatic pressure in the mesangium 
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pext   Hydrostatic pressure in Bowman’s space 
Π     Oncotic pressure in mesangium 
?⃗?      Surface normal vector 
φ     Fiber volume fraction, in mesangial matrix or perimesangial filtration barrier (PFB) 
r     Matrix fiber radius 
T    Temperature (K) 
𝑣     Plasma velocity 
 
2.2 Materials and Methods 
 Species transport in the mesangium is governed by convection due to plasma flow, 
diffusion due to chemical gradients, and reaction with other extracellular components 
and/or removal by the cells. For the present model, only convection and diffusion were 
considered. Importantly, the plasma flow rate depends not only on the mechanical 
pressure but also on the oncotic pressure, which in turn is determined largely by the 
albumin concentration (65). As a result, our model had three components: plasma flow, 
albumin transport, and IgA transport. The three components are described below. 
Plasma flow model. 
 Plasma flows through the mesangial matrix and composite perimesangial filtration 
barrier (PFB), which represents the composite resistance from the glomerular basement 
membrane and the podocyte layer. The average pore size in the mesangium is ≈ 20 nm 
(53), forcing a low flow rate where inertial effects are negligible. Furthermore, since the 
pore size is very small compared with mesangial dimensions of 1–3 mm (42, 77), the 
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problem may be further simplified to Darcy flow, governed by: 
𝑣 = −𝐾𝐷,𝑚𝑒𝑠∇𝑝 0.1 
0 = ∇ ∙ (𝐾𝐷,𝑚𝑒𝑠∇𝑝)  0.2 
Here, 𝑣  is the superficial velocity, KD,mes is the hydraulic conductivity of the 
mesangium, and p is the local pressure. The Darcy model has been used to describe 
interstitial flow in many tissues (13, 24, 51, 71, 87). Hydraulic conductivities for the 
mesangial matrix and filtration barrier were calculated as KD = κ/μ, where μ is the 
viscosity of plasma, and κ is the tissue’s Darcy permeability. Two different permeabilities 
were used, one for the mesangium to calculate KD,m, and one representing the resistance 
of the PFB to calculate KD,PFB, the perimesangial filtration barrier hydraulic conductivity. 
Permeability was calculated from fiber radius (r) and fiber volume fraction (φ ) (15): 
𝜅 =
3𝑟2
20𝜙
(− ln𝜙 − 0.931)  0.3 
 
 Boundary conditions on equation 2.1 were (see figure 2-1): 
 The pressure in the capillary was defined to be the baseline pressure and set to 35 
mmHg. 
 The hydrostatic pressure in Bowman’s space was set to 1.3 mmHg, (i.e., 33.7 
mmHg below the average glomerular capillary pressure). At the filtration barrier 
boundary, the plasma flux was determined by the combination of oncotic and 
hydrostatic pressure (24). 
?⃗? ∙ 𝑣 = −𝐾𝐷,𝑚𝑒𝑠
𝜕𝑝
𝜕𝑦
=
−𝐾𝐷,𝑃𝐹𝐵
𝛿𝑃𝐹𝐵
(𝑝 − 𝑝𝑒𝑥𝑡 − Π)  0.4  
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Here, ?⃗?  is the surface normal, 𝑣  is the velocity, δPFB is the filtration barrier 
thickness, KD,PFB is the hydraulic conductivity of the filtration barrier, p is the 
hydrostatic pressure in the mesangium, and pext is the hydrostatic pressure in 
Bowman’s space. KD,PFB was calculated using equation 0.3, with values of r (2 Å) 
and φ (0.3) chosen to achieve reasonable mesangial flux rates (mesangial flux can 
only be a small fraction of single nephron glomerular filtration rate (SNGFR) 
(49). 
 Albumin in the filtering plasma increases the fluid’s oncotic pressure relative to 
Bowman’s space as it is well known to do in the glomerular capillary (21). The 
oncotic pressure was calculated from the local concentration of albumin, calb using 
an approximation to the Landis-Pappenheimer equation (63). 
Π = 𝑎1𝑐𝑎𝑙𝑏 + 𝑎2𝑐𝑎𝑙𝑏                             0.5 
Here calb is the concentration of albumin, and a1 and a2 are constants (listed in 
table 2-1). Because our model requires a diffusion coefficient which depends on 
size, albumin was used instead of total protein concentration in the osmotic 
pressure calculation. The albumin concentration (4 g/100 mL) is much higher than 
the IgA concentration in the plasma (0.2 g/100 mL), so IgA did not contribute to 
the oncotic pressure in most simulations. In cases with large accumulation of IgA, 
however, IgA concentrations can become significant. 
 All other boundaries had zero flux, representing either a symmetry condition or an 
impermeable barrier. The symmetry condition on the right hand boundary (fig 2-1 
B) represents the case where a second capillary is connected to the mesangial 
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region. We assumed the mesangial cell was impermeable to flow, leading to a no 
flux condition on the bottom boundary. 
Albumin Transport Model 
Albumin movement within the mesangium is modeled by the convection-diffusion 
equation, which describes the movement of molecules in a flow field, 
∇ ∙ (𝐷𝑎𝑙𝑏∇𝑐𝑎𝑙𝑏 − 𝑐𝑎𝑙𝑏𝑣 ) = 0              0.6 
 
The albumin transport model is coupled to the plasma flow model because the flow field 
depends on the albumin concentration through equation            0.5, and albumin 
concentration depends on the flow field through equation 0.6. Therefore, these equations 
had to be solved simultaneously. In equation 0.6, 𝑣  is the velocity obtained from 
equations 0.1 and 0.2, Dalb is the diffusion coefficient of albumin in the mesangial matrix, 
and it was assumed that there was negligible hindrance of albumin convection through 
the matrix. We calculated diffusion coefficients based on the size of the albumin 
molecule, and the pore size and fiber thickness of the mesangial matrix, using established 
models of diffusion through porous fibrous matrices (equation 0.7) (3). 
𝐷𝑎𝑙𝑏 = 𝐷0𝑒
−𝜋𝜙𝑏𝑒−0.84𝑓
1.089
             0.7 
 
 𝑏 = 0.174 ln
59.6
𝜆
 
𝑓 = (1 + 𝜆2)𝜙 
𝐷0 =
𝑘𝐵𝑇
6𝜋𝜇𝑎
                            0.8 
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Here, D0 is the free diffusion coefficient for the molecule, φ is the volume fraction 
occupied by the fibers, and λ is the ratio of the molecule radius (a) to radius of the fibers 
in the matrix. The boundary conditions for albumin transport were as follows: 
 The albumin concentration was constant at 4 g/100 mL (11) in the capillary 
(figure 2-1). 
 The basement membrane was assumed to be a perfect filter, so the total flux 
across the filtration barrier was zero. In this case, 𝑣 = 0 because water exits the 
mesangial matrix across the filtration barrier. Thus, the boundary condition was 
𝐷𝑎𝑙𝑏?⃗? ∙ ∇𝑐𝑎𝑙𝑏 − 𝑐𝑎𝑙𝑏?⃗? ∙ 𝑣 = 0             0.9 
 All other surfaces have symmetry boundaries, so the total flux is zero on those as 
well. In this case, however, there is zero velocity as well (𝑣  = 0), as described 
above, so 
𝐷𝑎𝑙𝑏?⃗? ∙ ∇𝑐𝑎𝑙𝑏 = 0            0.10 
IgA Transport Model 
The convection-diffusion equation also describes the movement of IgA complexes. 
∇ ∙ (𝐷𝐼𝑔𝐴∇𝑐𝐼𝑔𝐴 − 𝑐𝐼𝑔𝐴𝑣 ) = 0           0.11 
Diffusion coefficients were calculated using the diameter of monomeric and dimeric IgA, 
in fiber matrices with varying fiber thicknesses and fiber volume fractions. Because IgA 
is several times larger than albumin, its diffusion coefficient is significantly smaller. The 
boundary conditions for IgA transport were: 
 Constant concentration in the capillary of 0.2 g/100 mL (32) 
 No flux from all other surfaces, noting as in the case of albumin that the plasma 
velocity is zero at the impenetrable surfaces, but not zero at the filtration 
boundary. 
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Implementation 
A standard Galerkin finite element simulation was developed in Matlab and used 
to solve all equations. Linear basis functions were used on a 25,000 element mesh that 
was generated with rectangular brick elements, with a spacing of 0.1 μm into the depth of 
the mesangium, 0.01 μm along the height of the mesangium, and 1 μm along the length 
of the glomerular capillary. Each element had eight Gauss points, and the dimensions of 
the entire mesangial matrix region (figure 2-1) were 5 x 0.5 x 10 μm. A segregated 
solving scheme was used that first solved the Darcy flow problem, assuming zero 
concentrations for albumin, to output a pressure field. That pressure field was then used 
to calculate a velocity input to the convection-diffusion equation. This resulted in a new 
concentration distribution for albumin and IgA, and this concentration distribution was 
used to calculate an osmotic pressure. The osmotic pressure was fed back to the Darcy 
solver in the boundary condition, and the process iterated until the pressure solution 
stopped changing within a tolerance of 0.001. The results of this process were pressure at 
each node, and the concentrations of albumin and IgA at each node. Simulations were run 
on computers at the Minnesota Supercomputing Institute (MSI) on 4 processors. The 
problem was solved in three dimensions, but with no variation in the third direction, so 
concentration and velocity profiles are shown in two dimensions. 
Case Studies 
Our reference case was normal glomerular capillary blood pressure (35 mmHg) 
(86), basement membrane thickness (δbm = 0.4 μm (52)), basement membrane fiber radius 
of 2.0 Å and basement membrane volume fraction of 0.3, and IgA concentration of 0.2 
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g/100 mL (32). From this case, we examined the effects of a thin basement membrane 
(δbm = 0.1 – 0.3 μm (52)) and decreased IgA diffusion coefficient (increased molecular 
radius). We also examined the effect of mesangial matrix structure (increasing the 
mesangial matrix fiber volume fraction) since the deposition of mesangial matrix is a 
common response in glomerular disease (36). For the simulations in this study only 
mesangial fiber thickness was changed, with total fiber density kept constant. 
Parameters in the model were varied as follows: 
 Four different thicknesses of basement membrane were used: 100, 200, 
300, and 400 nm. 
 Mesangial matrix had a volume fraction of 0.05, 0.08, 0.1, 0.13 and 0.15, 
with a fiber radius of 2 nm. 
 The radius of IgA was set to 75 Å, and then 1.25 and 1.5 times this 
number. 
In addition, we also examined the effect of a reaction at the surface of the mesangial cell. 
In this case the boundary conditions for IgA were altered to simulate a pseudo-first-order 
reaction. The flux was set equal to a constant reaction rate, k, multiplied by the local IgA 
concentration. The reaction rate was varied among the values 1.38, 0.138, and 0.0138 
μm/s, based on published in vitro studies. 
2.3 Results 
Results from our reference case are shown in figure 2-3. Pressure is highest at the 
capillary, decreasing into the mesangium due to plasma loss into the urinary space (fig. 2-
3A). The pressure gradient drives flow into the mesangium and across the filtration 
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barrier (fig 2-3B). Transmesangial flow concentrates albumin by 1% (fig. 2-3C) and IgA 
by 20% (fig. 2-3D) in the mesangial interior, compared to capillary levels. Because the 
perimesangial filtration barrier in our model perfectly filters albumin, an oncotic pressure 
arises in the mesangium (fig. 2-3E) which opposes the hydrostatic pressure driving 
filtration. Thus, the flow (determined by pressure gradients) drives solute concentration, 
which in turn affects flow by altering the driving pressure. 
Mesangial flux changes with both filtration barrier thickness, as well as mesangial 
matrix permeability (fig. 2-4). Thinner filtration barriers have the largest effect, as they 
decrease the resistance of the entire mesangial region (fig. 2-4A). In contrast, changing 
the permeability of the mesangial matrix has little effect for thicker filtration barriers (fig. 
2-4B). However, at the thinnest filtration barrier tested (100 nm), mesangial matrix 
permeability is important. With the thinner filtration barrier, the resistance to flow from 
the mesangial matrix begins to approach the resistance from the filtration barrier, so 
changing mesangial matrix permeability has a significant influence on mesangial matrix 
flux. 
We investigated the effects of intrinsic glomerular factors on IgA accumulation. 
IgA accumulation increases dramatically with thinner basement membranes (fig. 2-5A), 
reaching values of 10 - 100x the serum concentration, in sharp contrast to the 1.2x 
concentration seen in the reference case. The larger mesangial fluxes due to thinner 
basement membranes (fig. 2-4) carry more IgA into the mesangial region. Because of 
IgA’s small diffusion coefficient, this increased convective flux creates steep 
counteracting concentration gradients and thus much higher total accumulation. IgA 
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accumulation also increases with increasing mesangial matrix fiber volume fraction (fig. 
2-5B). As the fiber volume fraction increases, the permeability of the mesangial matrix 
drops. Lower permeability under a constant pressure drop causes smaller mesangial 
fluxes (fig. 2-4B); simultaneously, the increased matrix density results in more hindrance 
to diffusion. These two effects compete, with lower convective fluxes tending to decrease 
accumulation, but more hindered diffusion tending to increase accumulation. The net 
result is increased IgA accumulation as the matrix volume fraction increases (fig. 2-5B). 
Dimerizing IgA increases its radius and has a similar effect on diffusion, but not on flow 
(fig. 2-6), because the IgA concentration is so low it does not affect viscosity or osmotic 
pressure. As the radius of IgA increases, it becomes harder for it to move through the 
porous mesangial matrix, and thus its accumulation increases dramatically. 
When a cell surface reaction at the fastest rate was added to the model, 
accumulation decreased or ceased altogether, depending on the rate of reaction. We 
investigated simple first-order reaction kinetics, which increase linearly with increasing 
substrate (IgA) concentration. For large reaction rates (k=1.38 μm/s), this resulted in the 
unreasonable result of a total absence of IgA accumulation (not shown). However, at 
lower reaction rates (k=0.138, and 0.0138 μm/s), accumulation still occurred but at lower 
amounts, depending on mesangial flux (fig. 2-7). In these cases, higher mesangial flux 
convected more IgA into the mesangium, which counteracted the loss from mesangial 
cell surface reaction. At lower fluxes, with k=0.138 μm/s, the reaction removed IgA more 
quickly than it could accumulate. For the lowest k value tested (0.0138 μm/s), IgA 
accumulated for all PFB thicknesses. 
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These results indicate that several different factors influence IgA mesangial 
accumulation, including perimesangial filtration barrier thickness, mesangial matrix 
permeability, and the radius of the diffusing IgA. These glomerular and species factors 
can be examined in terms of the way they affect convection and diffusion. 
Fundamentally, our model is a convection-diffusion model, so the importance of these 
factors lies in how they change convection and/or diffusion. Higher mesangial fluxes, 
which convect IgA, tend to increase accumulation. Higher diffusion coefficients, which 
allow the immunoglobulin to escape into the capillary, tend to decrease accumulation. 
Thus thinner PFBs, which allow increased mesangial flux, would tend to increase 
accumulation. Larger IgA radii, which decrease diffusion, also tend to increase 
accumulation. 
The relative importance of convection and diffusion are quantified by the Péclet 
number. The Péclet number is defined as vL/D where v is a characteristic velocity, L is a 
characteristic length scale, and D is the diffusion coefficient. The numerator, vL, 
quantifies the strength of convection while the denominator, D, quantifies the strength of 
diffusion. For our simulation results we calculated a Péclet number using the mean 
velocity at the entrance of the mesangium for v, the length of the mesangium towards the 
symmetry boundary for L, and the diffusion coefficient of IgA for D. Plotting the 
accumulation of IgA vs. the Péclet number (fig. 2-8) collapses all of the case studies in 
this work into a single curve. This general effect was also seen in the presence of a 
reaction on the mesangial cell surface (fig. 2-7), but as the reaction rate got larger, IgA 
removal by cell surface reaction became the dominant factor. 
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2.4 Discussion and Conclusions 
Although there is uncertainty in the specific parameter values used in this study, 
experimental measurements of blood velocity in the glomerular capillaries (98), 
mesangial dimensions (77), immunoglobulin and albumin diffusion coefficients (12, 16), 
mesangial pore sizes (88), and glomerular pressure drops suggest that transport in the 
mesangium is indeed near a Péclet number of order one. When the Péclet number is near 
one, convection and diffusion exert equal influence. As a result, even small changes to 
the strength of convection and/or diffusion, can greatly alter IgA transport. IgA 
accumulation will be highly sensitive to biological changes that result in increased or 
decreased plasma velocity or IgA diffusion, as shown schematically in Table 2-2.  
The solute-agnostic nature of the model here, combined with the universality of 
the underlying physical principles, suggests that any macromolecule or tracer that is large 
or considerably hindered by the mesangial matrix will concentrate in the mesangium. 
Lipoproteins fall within this size range, and thus their transport would be affected by the 
parameters varied here (filtration barrier thickness, mesangial matrix permeability, etc.). 
Lipoproteins have been implicated in kidney disease (40, 90), and studies have shown 
that lipoprotein concentrations can affect mesangial cell proliferation (66). Tracer studies 
with imposil and carbon have shown that the mesangium is an important clearance route 
(28, 48). Size-dependent accumulation in the mesangium has also been experimentally 
observed (14).  
A similar process appears to occur in amyloid disease of the kidney (23), with 
abnormal proteins (e.g., serum amyloid A protein (30)) exhibiting elevated serum levels 
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and subsequently concentration and fibrogenesis in the mesangium. In collagenofibrotic 
glomerulopathy (25), the species in question is an atypical collagen III molecule, but the 
mesangial accumulation is similar. Although the subsequent accumulation process and 
molecule-cell interactions vary with disease, and the model parameters would vary with 
molecule, it appears that the fundamental mechanisms explored herein are at work in 
many cases, and that the transport dynamics of the mesangium render it particularly 
vulnerable to diseases of macromolecular accumulation.  
Thus, we must conclude that the well-established tendency of macromolecules to 
accumulate in the mesangium (78) can be explained in terms of non-specific transport 
phenomena. This natural accumulation may be valuable in the healthy kidney, allowing 
the mesangium to function as sensitive monitor of serum proteins and to use its 
contractility to maintain proper glomerular function (78) or communicate changes is 
serum protein levels to the extraglomerular mesangium and juxtaglomerular apparatus via 
gap junction connections (96). In the case of disease, however, this tendency to 
accumulate macromolecules has a negative effect on mesangial function. Thus, the 
general transport processes must be considered in conjunction with the specific biological 
processes (e.g., cell-molecule interactions) to create a full picture of a mesangial disease.  
 Early investigations suggested a role for the mesangium in regulating glomerular 
capillary diameter (7), but later work demonstrated that large capillary size changes 
would not result from mesangial contraction (50). Nevertheless, mesangial cell 
contraction can change the surrounding matrix structure: contraction will increase the 
space available for plasma flow while maintaining constant fiber volume, thus decreasing 
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matrix fiber volume fraction (68). This drop in fiber volume fraction could have 
significant effects on macromolecule accumulation, as the increased permeability allows 
easier transport across the mesangial region. Since the mesangium connects adjacent 
glomerular capillaries, increased capillary to capillary transport may play a role in the 
attenuated responses to Ang II observed after mesangial cell injury (6).  
In the case of IgA nephropathy, certain factors are known to increase the risk of 
developing disease (92) without completely predicting it. Our model suggests that the 
association of thin basement membranes (TBM) with IgA nephropathy (19) might be due 
to TBM causing increased convection, which increases the IgA accumulation (fig. 2-4). 
Our model also provides insight into the findings that mesangial IgA deposition requires 
the presence of both IgA and soluble CD89 (sCD89) (5). Because smaller 
macromolecules more easily escape the mesangium (fig. 2-6), a IgA-sCD89 complex 
would concentrate significantly more than either IgA or sCD89 alone. Nephropathy 
development might hinge upon the decreased diffusion coefficient that results from 
complex formation and creates high mesangial concentrations. 
The transport model described here is simplified, as it ignores uptake by 
mesangial cells, which is important in IgA nephropathy and other diseases (79). Uptake 
could be added to the current modeling framework by introducing a reaction term at the 
mesangial cell surface (i.e., by modifying the boundary condition to allow flux into the 
cell).Such a change to the model would lead to other dimensionless groups, comparing 
the rate of reaction at the cell surface to convective or diffusive transport. Since 
mesangial cells rapidly clear many solutes (28, 29, 41), this dimensionless number may 
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be more important than the Péclet number. This model only considered the accumulation 
of IgA. In reality, accumulation per se is not sufficient to cause damage (92), but it is a 
necessary step in the process. Another simplification of the model was the assumption of 
no solute flux into the urinary space. Albumin is known to cross the filtration barrier (35), 
and if IgA also leaked across the filtration barrier, that would decrease accumulation. An 
extended model using estimated sieving coefficients for albumin and IgA at the filtration 
barrier (27) could address this issue. 
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Parameters used in the 
model 
Meaning Value 
μ Plasma viscosity 7 x 10
-4
 Pa·s (91) 
a1 Osmotic pressure 
coefficient 
1.63 mmHg/(g/dL) (63) 
a2 Osmotic pressure 
coefficient 
0.294 mmHg/(g/dL) (63) 
Table 2-1: Constants used in the model. Numbers in parentheses are references. 
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Physiological 
Change 
Diffusion Convection Péclet number IgA 
Accumulation 
Thinner 
basement 
membranes 
- ↑ ↑ ↑ ↑ ↑ ↑ 
Denser 
mesangial 
matrix 
↓ ↓ -/↓ ↑ ↑ ↑ ↑ 
Larger IgA 
radius 
↓ ↓ - ↑ ↑ ↑ ↑ 
Table 2-2: Different physiological changes can have similar effects on IgA accumulation if their effect 
on the Péclet number is similar 
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Figure 2-1: A: A sketch of glomerular capillaries with the adjacent mesangium. The simulation 
region is highlighted by dark black lines. The glomerular capillary was considered as a boundary 
condition. Only the mesangial matrix domain is shown in the figures. The perimesangial filtration 
barrier (PFB) was considered as the combination of the glomerular basement membrane and the 
podocytes. B: sketch of the simulation domain showing the pressure boundary conditions. 
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Figure 2-2: Albumin boundary conditions showing capillary concentrations on the left, with 
symmetry conditions on the right as well as front and rear faces. Albumin flux across the top (PFB) is 
defined to be zero. 
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Figure 2-3: Results for the base case with a filtration barrier thickness of 0.4 μm, volume fraction 
φm= 0.05, and rIgA = 75 Å. A: contour lines for the pressure in mmHg. The highest pressures are 
found at the capillary boundary, with the pressure quickly dropping as fluid is lost across the 
filtration barrier. B: streamlines of plasma flow in the mesangial matrix. The symmetry boundary 
condition on the right-hand side causes a sharp turn in plasma flow. C: Albumin concentration 
within the matrix. Albumin is very close to the plasma level throughout the mesangium. D: 
immunoglobulin A (IgA) concentration within the mesangial matrix. Because of its larger size, IgA 
diffuses more slowly and therefore concentrates more than albumin, rising 20% above its capillary 
concentration. E: oncotic pressure due to albumin in the mesangial matrix. This pressure 
significantly reduces the driving force of filtration. 
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Figure 2-4: A: as the filtration barrier becomes thinner, mesangial flux increases. Mesangial flux 
values are normalized by the value in the reference case. B: mesangial matrix fiber volume fraction 
has only a small effect for thicker filtration barriers (0.2– 0.4 μm). For a filtration barrier thickness 
of 0.1 μm, however, changing the mesangial matrix volume fraction has a noticeable effect. 
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Figure 2-5: Excess mesangial accumulation vs. filtration barrier thickness (A) and mesangial matrix 
fiber volume fraction (B). Excess mesangial IgA is the IgA in the mesangial matrix above the 
concentration in the capillary. The reference case is again marked with the large black square. 
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Figure 2-6: As the radius of IgA increases, the accumulation of IgA in the mesangium also increases. 
Results shown here are for IgA having a radius of 1x, 1.25x, and 1.75x, the actual radius of IgA. 
These results are with a filtration barrier thickness of 0.4 μm, and mesangial matrix volume fractions 
of 0.05, 0.08, and 0.1. 
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Figure 2-7: When a cell surface reaction is added to the model accumulation decreases. The 
magnitude of the decrease depends on the reaction rate, with faster reactions leading to less 
accumulation or even eliminating it altogether. 
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Figure 2-8: The accumulation of IgA in the mesangium for the cases plotted earlier but vs. the Péclet 
number. They form a smooth line, suggesting that accumulation depends significantly on Péclet 
number rather than the specific parameters of the simulation. 
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Chapter 3: Mesangial transport in the context of the 
glomerular tuft 
This chapter is part of the manuscript: 
Hunt, S. E., Dorfman, K. D., Segal, Y., & Barocas, V. H. The mesangium as a shunt and 
a sensor. Submitted to Physiological Reviews. 
 
3.1 Summary 
 Building on the work presented in the previous chapter, we extended our model to 
focus on the potential role of the mesangium in sensing overall blood composition. We 
created a model of the mesangium situated between two counter-currently flowing 
glomerular capillaries, and explored macromolecular accumulation under varying 
glomerular conditions. This work demonstrated that the mesangium can act as a shunt, 
allowing plasma and solutes to bypass glomerular capillary filtration, and as an 
accumulator, accumulating macromolecules to concentrations above their capillary level. 
3.2 Introduction 
 The mesangium’s previously discussed functions in maintaining homeostasis, 
involvement in inflammation, and connection to the JGA, all suggest a role for the 
mesangium as a process monitor within the larger control system for glomerular filtration 
and blood homeostasis. Any exploration of this potential role must begin, however, with 
an understanding of the movement of analytes within the mesangial microenvironment. 
The mesangium abuts the glomerular capillaries, and is open to flow from the capillary 
lumen through the fenestrated endothelium (46, 47). Analyses of whole glomeruli have 
shown that the mesangium connects capillary segments to each other and also to the 
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urinary space via filtration across the mesangial basement membrane (39). Two 
consequences of this structure arise. First, plasma flowing through the mesangium can 
bypass afferent to efferent filtration in the capillary, effectively shunting the flow. 
Second, this flow convects large, slowly diffusing molecules into the mesangial matrix, 
where they accumulate to concentrations above their capillary levels (47, 48), facilitating 
sensing. In this we work we create a finite element model to examine how such a shunt 
sensor system might operate. We identify a range of physiologically reasonable 
conditions under which transport within the mesangium concentrates extremely dilute 
solutes in the blood, i.e., amplifies the signal that would be sensed by receptors on 
mesangial cells.  
 
Glossary 
a1, a2 osmotic pressure coefficients 
calb concentration of diffusing albumin 
Dalb diffusion coefficient of albumin 
h thickness of mesangial channels 
𝑗 𝑚𝑒𝑠 net flux into mesangial region 
k permeability of capillary wall 
κ Darcy permeability of the mesangial matrix 
μ plasma viscosity 
?⃗?  surface normal vector 
PU pressure in the urinary space 
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PUF net ultrafiltration pressure 
p hydrostatic pressure 
Q volumetric flow through capillary 
S capillary surface area 
𝑣  plasma velocity 
 
3.3 Materials and Methods 
The complicated geometry of the glomerular capillaries was simplified as shown 
in figure 3-1. Capillaries were modeled as straight cylinders, with the abutting 
mesangium occupying a constant amount of surface area. The blood in the capillaries was 
assumed to be well mixed over the capillary cross-section, so concentrations at the 
mesangial surface were equal to bulk concentrations in the capillary. In order to model 
both capillary and mesangial transport, capillary volumetric flows and the resulting 
capillary concentrations were first calculated along a one-dimensional line following the 
capillary's axis. Changes in volumetric flow down the length (afferent to efferent) of the 
capillary due to filtration were calculated based on (81):  
𝑑𝑄
𝑑𝑧
= −𝑘𝑆𝑃𝑈𝐹   3.1  
Here Q is the volumetric flow rate, k is the permeability of the capillary wall, S is the 
filtration surface area of the capillary wall, and PUF is the net ultrafiltration pressure, 
which will be defined below. For an isolated capillary (i.e., one without a mesangium), 
the mass flow rate of a solute that cannot pass through the filtration barrier must remain 
constant, which results in  
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𝑑(𝑄𝑐)
𝑑𝑧
= 𝑐
𝑑𝑄
𝑑𝑧
+ 𝑄
𝑑𝑐
𝑑𝑧
= 0               
where c is the concentration of the solute of interest. Combined with equation 3.1, 
equation 3.2 implies that 
𝑑𝑐
𝑑𝑧
= −
𝑐
𝑄
𝑑𝑄
𝑑𝑧
=
𝑘𝑐𝑆𝑃𝑈𝐹
𝑄
  3.3 
The constant mass flow rate (M) allows us to write Q =
𝑀
𝑐
. This relationship is used with 
equation 3.3 to make an initial estimate of the albumin profile for the capillary, where the 
concentration of interest is calb. The pressure Pcap(z) along the capillary length was 
specified as a small linear pressure drop, and the net ultrafiltration pressure PUF was 
calculated as:  
𝑃𝑈𝐹 = 𝑃𝑐𝑎𝑝 − 𝑃𝑈 − 𝑎1𝑐𝑎𝑙𝑏 − 𝑎2𝑐𝑎𝑙𝑏
2
 3.4 
In equation 3.4, PU is the urinary pressure and a1 and a2 are constants used to calculate the 
oncotic pressure (63, 74). Given an inlet volumetric flow (Q0), initial albumin 
concentration (c0,alb = 5.8 g/dL (10)), and urinary pressure (PU is 34 mmHg below 
capillary pressure), equations 3.3, and 3.4 allow us to calculate the albumin concentration 
profile for the isolated capillary. Once the albumin profile is calculated, the same 
equations can be used to calculate the concentration profile for any solute of interest.   
We used a segregated solving scheme for the coupled capillary-mesangium 
problem. First, equations 3.1 and 3.5, (shown below), were solved for the capillary to 
calculate a concentration profile and volumetric flux along the capillary. Next, the 
capillary concentration and pressure profiles were passed as boundary conditions to the 
mesangial matrix model. The pressure and concentration in the mesangial region were 
then calculated via an extended version of the method previously described (38). Briefly, 
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plasma flow through the mesangial region was assumed to be governed by Darcy's law 
for an incompressible fluid (eq. 3.5), with pressure depending on the mechanical and 
osmotic pressure differences between the mesangium and the urinary space.  
∇ ∙ 𝑣 = ∇ ∙ (−
𝜅
𝜇
∇𝑝) = 0               3.5 
In equation 3.5 μ is the plasma viscosity and κ is the Darcy permeability of the mesangial 
matrix. Darcy permeabilities were calculated based on the volume fraction of fibers in the 
mesangial matrix and the radius of those fibers as in (38).  
 
Transport of solutes was governed by the convection-diffusion equation (eq. 3.6), 
and all solutes were assumed to have free access from the glomerular capillaries into the 
mesangial region (valid for solutes less than 40.5 nm in mean length (46)).  
∇ ∙ (𝐷𝑎𝑙𝑏∇𝑐𝑎𝑙𝑏 − 𝑐𝑎𝑙𝑏𝑣 ) = 0            3.6 
In equation 3.6 Dalb is the hindered diffusion coefficient of albumin, estimated using 
established models of diffusion through porous fibrous matrices (38).  The computed 
mesangial region pressure and concentration profiles were then used to calculate the 
plasma flux (𝑗 𝑚𝑒𝑠) into (or out of) the adjacent capillaries:  
𝑗 𝑚𝑒𝑠 = −2?⃗? (
𝜅
𝜇
∇𝑝)|
𝑚𝑒𝑠−𝑐𝑎𝑝
ℎ            3.7 
In equation 3.7, h is the height of the mesangial matrix, p is the pressure in the matrix, 
and ?⃗?  is the surface normal unit vector. The factor of 2 results from the geometry shown 
in figure 3-1, with two mesangial regions for each capillary. These fluxes were combined 
with the capillary filtration in the mass balance on plasma to yield an update to equation 
3.1: 
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𝑑𝑄
𝑑𝑧
= −(𝑘𝑆𝑃𝑈𝐹 + 𝑗 𝑚𝑒𝑠)            3.8 
Combining equation 3.7 with equation 3.8 results in  
𝑑𝑄
𝑑𝑧
= −𝑘𝑆𝑃𝑈𝐹 + 2?⃗? ∙ (
𝜅
𝜇
∇𝑝)|
𝑚𝑒𝑠−𝑐𝑎𝑝
ℎ            3.9 
Equation 3.9 describes the plasma flow (Q). The flux of solutes into/out of the 
mesangium was also calculated:  
𝑗 𝑠𝑜𝑙𝑢𝑡𝑒|𝑚𝑒𝑠 = (−𝐷∇𝑐 − 𝑐
𝜅
𝜇
∇𝑝) ∙ ?⃗?            3.10 
Here, D is the diffusion coefficient for the solute in question, and c is the solute 
concentration. For a capillary without an adjacent mesangium, the solute flow along the 
capillary, Qc, would be a constant. However, for a capillary with a mesangium that is 
open to fluid flow, solutes can be lost or gained through flux from the mesangium. The 
solute concentration equation (equation 3.3) then becomes:  
𝑑(𝑄𝑐)
𝑑𝑧
= 2ℎ?⃗? ∙ (𝐷∇𝑐 + 𝑐
𝜅
𝜇
∇𝑝)|
𝑚𝑒𝑠−𝑐𝑎𝑝
           3.11 
Equations 3.9 and 3.11 were solved simultaneously to get c(z), the protein profile along 
the capillary length. This concentration profile was then used as a boundary condition on 
the mesangial matrix, and the process was iterated until the solution had converged 
(within 0.001).  
To represent countercurrent flow, a linear pressure drop in the positive z-direction 
was specified as a boundary condition on one side (the afferent side) of the mesangial 
matrix, while a linear pressure drop in the negative z-direction was specified on the 
opposite (efferent) side of the mesangial matrix. Input concentrations of albumin and IgA 
were set on the afferent side. Then the pressure and concentrations at the entrance to the 
efferent side were set equal to the pressure and concentrations at the exit from the 
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afferent side. The characteristics of mesangial transport were examined for solutes 
ranging in size from an overall radius of 47 to 98.25 Å. 
 
3.4 Results 
Flow and Pressure Field 
 The large-scale nature of mesangial transport depends strongly on fundamental 
physiological parameters. Figure 3-3 shows the streamline and pressure profiles for two 
contrasting cases, selected to demonstrate different parametric regimes. Figure 3-3A 
shows streamlines for a basement membrane thickness of 0.4 μm and matrix volume 
fraction of 0.05. Here, the blood plasma flows from the afferent capillary through the 
mesangial matrix to the efferent capillary. In this case, the loose mesangial matrix, in 
combination with the high resistance to flow from the thick basement membrane, acts as 
a shunting channel, providing a conduit for the movement of solutes and water from one 
capillary to another. This shunting slightly raises the solute concentration in the efferent 
capillary, and lowers it in the afferent, but the effect is small (~10%). Figure 3-3B shows 
the streamlines for a basement membrane thickness of 0.1 μm and a mesangial matrix 
volume fraction of 0.15. In this case, the thin basement membrane provides low 
resistance to plasma entering the urinary space, and the thicker matrix obstructs 
intercapillary flow. As a result, plasma enters the mesangium from both capillaries and 
exits across the basement membrane into the urinary space. In this situation the mesangial 
matrix provides additional filtration surface area, beyond that of the glomerular capillary 
walls.  
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This dramatic difference in streamline profiles results from the interaction 
between two different resistances to flow: the basement membrane and the mesangial 
matrix. The basement membrane resists fluid flow more than the mesangial matrix in all 
cases, but as the resistance of the mesangial matrix increases towards that of the 
basement membrane, plasma moves into the mesangial interior from both capillaries and 
then filters through the mesangial basement membrane, as shown in figure 3-4A,D. In 
contrast, when the resistance from the mesangial matrix is far below that of the basement 
membrane, shunting flow (as shown in figure 3-4G,J) results. The relative resistance 
between these two flow paths can be captured by the dimensionless ratio Ψ =
𝜅𝐵𝑀𝐿𝑚𝑒𝑠
𝜅𝑀𝛿𝐵𝑀
. In 
figure 3-4A-F, we had Ψ = 0.071, whereas figure 3-4G-I was calculated for Ψ =0.0028. 
 
Species Distribution 
The factor Ψ, which is large if the basement membrane is highly permeable and the 
mesangium is not, clearly affects distribution of solutes within the mesangium. In 
addition, because there are both convection and diffusion within the mesangium, the 
Péclet number (vL/D), which captures the relative contributions of convection and 
diffusion, must also play a role. Concentration profile results for four limiting cases are 
shown in figure 3-4. In that figure, the molecular size of the transported species was 
adjusted to maintain consistent Péclet numbers for panels A-C, G-I and C-D,J-L. 
 
Figure3- 4A-C (the shunting case) shows the streamlines for plasma flow (3-4A), the 
diffusive (3-4B) and convective (3-4C)  species fluxes, and the concentration of a large 
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molecule in the case where the basement membrane is thick (0.4 μm), and the mesangial 
matrix is loose (φ = 0.05). The loose matrix allows an effective diffusion coefficient of ≈ 
4.1 μm2/s, but the convective fluxes still dominate the overall transport of material 
(Figure 3-4C). As a result, the convection sweeps large molecules through the 
mesangium, and they do not accumulate to high levels. The concentration in the 
mesangial matrix is only 5% above the bulk concentration in the capillary.  
In contrast, figure 3-4D-F (the accumulating case) shows the mesangial 
concentrations with a thin basement membrane (0.1 μm) and dense mesangial matrix (φ = 
0.15). Here, the effective diffusion coefficient is reduced due to hindering, maintaining a 
fairly large Péclet number (Pé = 2.79) in spite of the reduced flow rates. As seen in figure 
3-4D, the convective fluxes from both the afferent and efferent capillaries carry material 
into the mesangium, and diffusive fluxes move out of the mesangial region to both 
afferent and efferent capillaries to maintain the system at equilibrium. The net result of 
the diffusive and convective influence is a very low magnitude movement from efferent 
to afferent and high accumulation in the mesangial region, with concentrations reaching 
four times the circulating plasma levels.  
In contrast, solutes whose transport is governed by diffusion (Péclet numbers less 
than one) move from the high concentration capillary (afferent) to the low concentration 
capillary (efferent) (figure 3-4A-C,G-I) . For both values of Ψ in this column, large 
solutes do not accumulate, but rather recirculate within the capillary loop, opposite of 
convection.   
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Since diffusion dominates under these conditions, the ideas of shunting and 
accumulation do not apply. Rather, the species simply diffuse across the mesangium 
because of the slight concentration difference between the afferent and efferent 
capillaries. 
 
3.4 Discussion 
The most significant result of this work is the identification of different functional 
regimes within the possible parameter space of mesangial transport. In particular, we 
have identified some situations (“shunting”) in which the mesangium could potentially 
allow plasma and species to move from an afferent to an efferent arteriole without 
passing through the full length of glomerular capillary filtration. In other situations 
(“accumulating”), however, the mesangium acts as additional filtration surface area, 
beyond that provided by the capillary walls, and can accumulate species.  
Shunting occurs when the basement membrane is thick and the mesangial matrix 
is loose. Under these conditions, the mesangial matrix provides a pathway of little 
resistance to fluid flow, and the basement membrane resists filtration into the urinary 
space. Because of the loose mesangial matrix, species carried by the flow can easily enter 
and exit the mesangial space. This flow does not appear to have a significant impact on 
capillary concentrations, which are much more sensitive to filtration across the 
glomerular capillary wall. Binding to mesangial cell receptors were not considered in this 
model, but such reactions are well established (29, 31, 34, 90). In the presence of 
mesangial cell binding, concentrations in the mesangial interior could change 
significantly, and the shunting flow could become important. 
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The more interesting case is that of accumulation. When the basement membrane 
is thin and the mesangial matrix is dense, plasma and solutes move from both the afferent 
and efferent capillaries into the mesangial interior. Here, the mesangium provides 
additional filtration surface, with plasma being filtered across the mesangial basement 
membrane. The dense matrix highly hinders the diffusion of solutes, particularly large 
solutes, which causes a dramatic increase in their concentrations in the mesangium. Thus 
the mesangium could be extremely sensitive to even small changes in the circulating 
plasma concentrations of key analytes. Consistent with this idea, multiple studies have 
established the movement of tracers and molecules from the circulation into the 
mesangial matrix (28, 29, 41, 48, 53). Evidence also shows that the mesangium reacts 
early in the progress of glomerular disease (36, 59, 80). Our results shed light on the 
physiological conditions that may lead to mesangial response. 
Mesangial cells exist in a unique microenvironment, and can react to a 
combination of molecular signals (67, 82, 86), mechanical cues (33, 55, 76, 97), and/or 
electrical signals(69, 86, 96). Based on the current work, it is possible for analyte 
concentrations in the mesangium to reach several times those in the circulating plasma, 
which could be extremely important in terms of molecular signal processing. If the cells 
in the mesangium are serving as sensors to monitor the blood’s health (83), then the 
mesangial architecture could act as an amplifier to provide those sensors with the highest 
possible signal-to-noise ratio. The amplification would be favorable both in the case of 
mesangial cells contributing to the maintenance of hemeostasis, and in the case of 
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immune cells reacting to inflammatory cues (4, 78). Furthermore, accumulation of 
species could facilitate clearance by the mesangial cells (20, 48, 54, 56). 
 
 
 
 
. 
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Parameter Meaning Value 
a1 Osmotic pressure constant 
1.63 mmHg/(g/dL)(74)  
a2 Osmotic pressure constant 
0.294 mmHg/(g/dL)
2
(74) 
h 
Mesangial channel width 
0.5 μm (estimated) (43, 77) 
μ 
Plasma viscosity 
1.35 x 10
-3
 Pa∙s (91) 
PU Urinary space pressure 
34 mmHg below capillary 
pressure (10) 
Q0 Initial volumetric plasma 
flow rate 
8.3 x 10
5
 μm3/s (22) 
R 
Capillary radius 
5 μm (72) 
c0,alb 
Initial concentration of 
albumin 
5.8 g/dL (10) 
Table 3-1: Values for constants used in the model. Numbers in parentheses are references. 
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Figures 
 
 
 
Figure 3-1: A sketch of the geometry used in the model. R is the capillary radius, m is the width of the 
entire mesangial region, and h is the width of the mesangial matrix channels. The central rectangle 
represents the impermeable mesangial cell, and the dashed line is a line of symmetry used to simplify 
calculations. 
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Figure 3-2: Model boundary conditions. Symmetry boundary conditions are used at high and low 
values of z. Plasma filters across the basement membrane, but it is completely impermeable to 
solutes. 
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Figure 3-3: Plasma flow streamlines through the glomerular mesangium between an afferent (A) and 
an efferent (E) capillary for two different cases. Streamlines terminate when they hit the mesangial 
boundary. A) Plasma streamlines for the case where δBM =0.4 μm and φm = 0.05. Here, the thick 
basement membrane has a high resistance to filtration into the urinary space. In combination with a 
loose mesangial matrix, plasma shunts from the afferent capillary to the efferent capillary, with 
relatively little crossing into the urinary space. In this situation the mesangial matrix acts as a 
channel for fluid to move from the afferent to the efferent side. B) Flow for the case where δBM =0.1 
μm, and φm = 0.15. Here, a thinner basement membrane offers much less resistance to filtration into 
the urinary space. Combined with the high resistance to inter-capillary flow offered by the dense 
mesangial matrix, plasma quickly begins to filter into the mesangium from both the afferent capillary 
and the efferent capillary. 
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Figure 3-4: Fluxes and large molecule distribution over Ψ and the Péclet number. Streamlines 
terminate at the top boundary, the basement membrane. A-C) In panels A – C, Pé = 0.34, Ψ = 0.071, 
δBM = 0.1, and φ = 0.15. 3A shows the pressure profile and convective flux of the large molecule, B 
shows the concentration profile and diffusive flux, and C shows the total flux of a large molecule . 
Here the low Péclet means that despite the high value of Ψ, little accumulation in the mesangial 
region occurs. Instead, the solute diffuses from the high concentration capillary (afferent) to the low 
concentration capillary (efferent) as seen in panel C. D-F) In panels D – F, Pé = 2.79, and  Ψ = 0.071, 
δBM = 0.1, and φ = 0.15. The three panels again show convective flux, diffusive flux, and total flux 
respectively. Here, the large Péclet number causes extensive mesangial accumulation as convection in 
from both capillaries dominates.  G-I) In panels G-I,  Pé = 0.34, Ψ = 0.0028, δBM = 0.4, and φ = 0.05. 
Again, the small Péclet number results in no accumulation and the transport is diffusion dominated. 
J-L) In panels J-L, Pé = 2.79, Ψ = 0.0028, δBM = 0.4, and φ = 0.05. Here, although the Péclet number is 
large (which caused extensive accumulation for large values of Ψ), the small value of Ψ causes a 
convective flow from afferent to efferent. Thus the convection-dominated transport sweeps solutes to 
the efferent capillary with little mesangial accumulation. 
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Chapter 4: Discussion and Conclusions 
 
 
 A major contribution of this work is to outline the parameters that influence 
transport in the glomerular mesangium, and to define their contribution to key 
dimensionless groups. The model suggests that mesangial transport is strongly influenced 
by the Péclet number, and, with the inclusion of cell surface receptor binding, also by a 
dimensionless group that compares receptor reaction rate to diffusion or convection. 
Macromolecule accumulation in the mesangium has been observed for a long time, and 
its role in glomerular disease is also well known. However, this model builds a 
connection between the architecture of the mesangium – its central location, porous 
matrix, and endothelial connection – and these observations. It also suggests a physical 
explanation for certain clinical correlations, such as the association of IgA nephropathy 
with thin basement membranes. The extended model of mesangial transport between 
glomerular capillaries provides a new dimensionless group, Ψ, which compares 
mesangial matrix and basement membrane resistances. The ability of this parameter to 
drastically change the mesangial microenvironment suggests that the mesangial cell’s 
deposition of extra mesangial matrix in response to inflammatory cues may be uniquely 
counterproductive. This parameter based analysis also gives a new perspective from 
which to evaluate potential therapeutic strategies. Therapies that directly manipulate 
these key parameters, e.g. decreasing the Péclet number by increasing matrix digestion or 
blocking matrix deposition, may be just as effective as attempting to block key cell 
receptors 
  52 
Given the sensitivity of the mesangial microenvironment to changes in Péclet 
number and Ψ, the inflammatory response of mesangial cells and immune cells may 
aggravate disease progression rather than return the glomerulus to healthy homeostasis. 
The next step in this work would be to include this dynamic response in the 
computational model. The current work is limited by the use of steady-state equations at 
every step. The glomerulus is clearly not a steady-state system. However, the time scale 
difference between convection and diffusion on the one hand, and matrix 
deposition/degradation or mesangial cell proliferation on the other hand, would allow a 
relatively simple model of remodeling that uses the existing steady-state model in a 
feedback loop with a model of mesangial cell responses to key signals. Such a model of 
mesangial cell biology, in combination with the model of mesangial transport, could 
provide key insights into glomerular disease progression. 
More broadly, whole areas of mesangial biology and anatomy were ignored in 
this work. The model does not include any electrical signaling or interaction with the 
JGA. Mechanical signaling was also ignored, and could also easily be added to the 
model. Our brief investigation of receptor binding kinetics highlighted its importance, so 
further incorporation of more detailed receptor kinetics models might improve the 
validity of this model. Lastly, all this work is based on highly simplified geometries. As 
has been previously demonstrated (73), while simplified geometric models can provide 
good overall insight into the basic physics of filtration, incorporating the details of the 
true glomerular structure can change model outputs significantly. A whole glomerulus 
model of mesangial transport would eliminate the artificial symmetry boundaries in the 
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current model, and could give insight into the intra-glomerular to extra-glomerular 
transport that has been observed. Despite these limitations, the existing model extends 
our knowledge of transport in the glomerulus, and outlines some key operating spaces in 
which the mesangium can function. 
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